首页> 外国专利> CELL GROWTH INHIBITOR USING SPHINGOSINE KINASE 2, METHOD OF CONSTRUCTING FUSED PROTEIN HAVING ITS NUCLEAR LOCALIZATION SIGNAL, METHOD OF SCREENING DRUG CANDIDATE, AND SCREENING KIT

CELL GROWTH INHIBITOR USING SPHINGOSINE KINASE 2, METHOD OF CONSTRUCTING FUSED PROTEIN HAVING ITS NUCLEAR LOCALIZATION SIGNAL, METHOD OF SCREENING DRUG CANDIDATE, AND SCREENING KIT

机译:使用鞘氨醇激酶2的细胞生长抑制剂,构建融合蛋白的核定位信号的方法,筛选候选药的方法以及筛选试剂盒的方法

摘要

It is intended to provide medically and industrially useful substances and methods based on the analysis of the function of sphingosine kinase 2 (SPHK2). As the results of the analysis on the function of sphingosine kinase 2 (SPHK2), it is found out that SPHK2 occurs mainly in the nucleus of a cell and has a nuclear localization signal (NLS) in its amino-terminal side, DNA synthesis in cells is inhibited by expressing SPHK2, SPHK2 should be present in the nucleus to exert its effect of inhibiting the DNA synthesis, etc. Therefore, SPHK2 is usable as a cell growth inhibitor and its NLS sequence is applicable to the construction of a novel fused protein or the like, which makes them medically and industrially useful.
机译:旨在基于鞘氨醇激酶2(SPHK2)的功能分析,提供医学和工业上有用的物质和方法。对鞘氨醇激酶2(SPHK2)的功能进行分析的结果表明,SPHK2主要存在于细胞核中,在其氨基末端具有核定位信号(NLS),DNA合成在细胞通过表达SPHK2受到抑制,SPHK2应该存在于细胞核中以发挥其抑制DNA合成的作用等。因此,SPHK2可用作细胞生长抑制剂,其NLS序列可用于构建新型融合蛋白等等,这使它们在医学和工业上都有用。

著录项

  • 公开/公告号AU2003292636A1

    专利类型

  • 公开/公告日2004-07-29

    原文格式PDF

  • 申请/专利权人 THE NEW INDUSTRY RESEARCH ORGANIZATION;

    申请/专利号AU20030292636

  • 发明设计人 SHUN-ICHI NAKAMURA;TARO OKADA;

    申请日2003-12-25

  • 分类号C12N15/12;A61P43/00;G01N33/15;G01N33/50;C07K19/00;C12Q1/02;C12Q1/48;C12N5/10;C12P21/02;C12N9/12;A61K38/45;A61K45/00;A61K48/00;

  • 国家 AU

  • 入库时间 2022-08-21 23:01:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号